1. Home
  2. TG vs OBIO Comparison

TG vs OBIO Comparison

Compare TG & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

N/A

Current Price

$7.94

Market Cap

262.4M

Sector

Industrials

ML Signal

N/A

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$5.44

Market Cap

253.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TG
OBIO
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.4M
253.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TG
OBIO
Price
$7.94
$5.44
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.25
AVG Volume (30 Days)
172.2K
286.0K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
33.13
EPS
0.34
N/A
Revenue
$800,821,000.00
$33,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.43
P/E Ratio
$23.44
N/A
Revenue Growth
8.29
1169.22
52 Week Low
$6.25
$2.20
52 Week High
$10.53
$5.78

Technical Indicators

Market Signals
Indicator
TG
OBIO
Relative Strength Index (RSI) 52.41 73.43
Support Level $7.29 $4.07
Resistance Level $8.20 N/A
Average True Range (ATR) 0.38 0.30
MACD -0.01 0.10
Stochastic Oscillator 22.60 80.29

Price Performance

Historical Comparison
TG
OBIO

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: